Hong Kong stocks' innovative drug sector continued to decline in the afternoon, with Innovent Biologics (02096.HK) falling nearly 12%, having risen by more than 6% at the beginning of the session. Luye Pharma (02186.HK) fell nearly 11%, Zai Lab (09688.HK) fell more than 7%, and CSPC Pharmaceutical Group (01093.HK) fell more than 6%.